Evolv Technologies Holdings, Inc. provided earnings guidance for the year 2022. For the year, the company expected total revenue to be in the range of $29 million to $31 million. Operating loss to be $82 million to $84 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.755 USD | +2.04% | +2.80% | -41.63% |
May. 22 | Lee Health Selects Evolv Technology For Weapons Detection | CI |
May. 21 | Virtua Health Adds Evolv Technology as its Weapons Detection Partner | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.63% | 431M | |
-5.93% | 42.08B | |
-4.93% | 10.53B | |
-11.82% | 7.36B | |
+3.67% | 6.37B | |
+14.56% | 3.15B | |
+8.15% | 2.27B | |
+51.18% | 1.91B | |
+5.13% | 1.68B | |
+4.00% | 1.54B |
- Stock Market
- Equities
- EVLV Stock
- News Evolv Technologies Holdings, Inc.
- Evolv Technologies Holdings, Inc. Provides Earnings Guidance for the Year 2022